Ellenbecker Investment Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $991K | Buy |
7,714
+200
| +3% | +$23.4K | 0.12% | 51 |
|
|
2026
Q1 | $904K | Buy |
7,514
+561
| +8% | +$64.8K | 0.12% | 52 |
|
|
2025
Q4 | $732K | Sell |
6,953
-15
| -0.2% | -$1.41K | 0.1% | 59 |
|
|
2025
Q3 | $585K | Sell |
6,968
-7
| -0.1% | -$577 | 0.09% | 64 |
|
|
2025
Q2 | $552K | Sell |
6,975
-8
| -0.1% | -$636 | 0.09% | 61 |
|
|
2025
Q1 | $627K | Sell |
6,983
-286
| -4% | -$26.7K | 0.11% | 58 |
|
|
2024
Q4 | $723K | Buy |
7,269
+1,211
| +20% | +$125K | 0.13% | 52 |
|
|
2024
Q3 | $688K | Sell |
6,058
-1,241
| -17% | -$147K | 0.13% | 51 |
|
|
2024
Q2 | $904K | Buy |
7,299
+1,095
| +18% | +$141K | 0.18% | 44 |
|
|
2024
Q1 | $819K | Sell |
6,204
-42
| -0.7% | -$5.18K | 0.17% | 46 |
|
|
2023
Q4 | $681K | Sell |
6,246
-1,124
| -15% | -$117K | 0.16% | 51 |
|
|
2023
Q3 | $758K | Buy |
7,370
+912
| +14% | +$98.3K | 0.2% | 46 |
|
|
2023
Q2 | $745K | Buy |
6,458
+358
| +6% | +$40.6K | 0.19% | 45 |
|
|
2023
Q1 | $648K | Buy |
6,100
+36
| +0.6% | +$3.89K | 0.18% | 44 |
|
|
2022
Q4 | $672K | Buy |
6,064
+216
| +4% | +$22.1K | 0.2% | 41 |
|
|
2022
Q3 | $503K | Buy |
5,848
+76
| +1% | +$6.79K | 0.16% | 44 |
|
|
2022
Q2 | $526K | Buy |
5,772
+181
| +3% | +$16K | 0.16% | 44 |
|
|
2022
Q1 | $458K | Sell |
5,591
-8
| -0.1% | -$631 | 0.13% | 50 |
|
|
2021
Q4 | $429K | Buy |
5,599
+90
| +2% | +$7.17K | 0.12% | 52 |
|
|
2021
Q3 | $413K | Buy |
5,509
+19
| +0.3% | +$1.45K | 0.13% | 42 |
|
|
2021
Q2 | $427K | Sell |
5,490
-442
| -7% | -$32.9K | 0.14% | 43 |
|
|
2021
Q1 | $436K | Buy |
5,932
+305
| +5% | +$22.5K | 0.15% | 41 |
|
|
2020
Q4 | $439K | Buy |
5,627
+1
| +0% | +$76 | 0.16% | 39 |
|
|
2020
Q3 | $445K | Buy |
5,626
+526
| +10% | +$41.2K | 0.19% | 36 |
|
|
2020
Q2 | $376K | Buy |
5,100
+213
| +4% | +$16K | 0.19% | 37 |
|
|
2020
Q1 | $359K | Buy |
4,887
+94
| +2% | +$7.39K | 0.23% | 34 |
|
|
2019
Q4 | $416K | Hold |
4,793
| – | – | 0.22% | 36 |
|
|
2019
Q3 | $385K | Sell |
4,793
-1
| -0% | -$80 | 0.22% | 36 |
|
|
2019
Q2 | $383K | Buy |
4,794
+1
| +0% | +$77 | 0.22% | 37 |
|
|
2019
Q1 | $380K | Hold |
4,793
| – | – | 0.24% | 38 |
|
|
2018
Q4 | $349K | Hold |
4,793
| – | – | 0.27% | 36 |
|
|
2018
Q3 | $324K | Hold |
4,793
| – | – | 0.24% | 39 |
|
|
2018
Q2 | $278K | Hold |
4,793
| – | – | 0.22% | 42 |
|
|
2018
Q1 | $249K | Hold |
4,793
| – | – | 0.21% | 39 |
|
|
2017
Q4 | $257K | Buy |
+4,793
| New | +$266K | 0.21% | 40 |
|
Other funds holding MRK
Ellenbecker Investment Group's MRK Position: Q2 2026 in Review
Ellenbecker Investment Group increased its Merck (MRK) stake by 2.7% in Q2 2026, buying an estimated $23.4K and bringing the position to 7,714 shares worth $991K. The position accounts for 0.12% of the portfolio, ranked #51.
Ellenbecker Investment Group first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. 3,832 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Ellenbecker Investment Group held 7,714 shares of Merck worth $991K as of Q2 2026.
- Ellenbecker Investment Group bought 200 Merck shares in Q2 2026, an estimated $23.4K.
- Merck made up 0.12% of Ellenbecker Investment Group's portfolio in Q2 2026, its #51 holding.
- Ellenbecker Investment Group first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
- 3,832 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Ellenbecker Investment Group's 13F filing for Q2 2026, filed 27 Jul 2026.